Home
About
FAQ
History (16)
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.
Switch of NAD Salvage to de novo Biosynthesis Sustains SIRT1-RelB-Dependent Inflammatory Tolerance.
Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score.
Nitrofurantoin neuropathy: a forgotten adverse effect.
Lung-On-A-Chip Technologies for Disease Modeling and Drug Development.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Lung-On-A-Chip Technologies for Disease Modeling and Drug Development.
Konar D, Devarasetty M, Yildiz DV, Atala A, Murphy SV. Lung-On-A-Chip Technologies for Disease Modeling and Drug Development. Biomed Eng Comput Biol. 2016; 7(Suppl 1):17-27.
View in:
PubMed
authors with profiles
Anthony Atala MD
Sean V. Murphy PhD